Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jae-Min | - |
dc.contributor.author | Kim, Sung-Wan | - |
dc.contributor.author | Stewart, Robert | - |
dc.contributor.author | Kim, Seon-Young | - |
dc.contributor.author | Yoon, Jin-Sang | - |
dc.contributor.author | Jung, Sung-Won | - |
dc.contributor.author | Lee, Min-Soo | - |
dc.contributor.author | Yim, Hyeon-Woo | - |
dc.contributor.author | Jun, Tae-Youn | - |
dc.date.accessioned | 2021-09-07T16:27:10Z | - |
dc.date.available | 2021-09-07T16:27:10Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-01 | - |
dc.identifier.issn | 0885-6222 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/113337 | - |
dc.description.abstract | Objective To estimate the 12-week remission rate of patients with depressive disorders and predictors of this in a naturalistic clinical setting in South Korea. Methods For people with DSM-IV depressive disorders about to receive treatment at 18 hospitals, data on sociodemographic and health status were obtained. A free choice of clinical interventions was allowed and naturalistic follow-up took place at 1, 2, 4, 8, and 12 weeks later. Remission was defined as a Hamilton Depression Rating Scale score of <= 7 sustained to 12 weeks or last follow-up, if earlier. Results For 723 participants, the 12-week remission rate was 31.4%. Remission was more likely in women, and in patients without a prior history of suicide attempt, and those with lower baseline anxiety. Conclusions Remission associated with unrestricted clinical interventions was comparable to STAR*D estimates for citalopram alone. Comorbid anxiety and previous suicide attempt were markers of worse outcome. Copyright (C) 2011 John Wiley & Sons, Ltd. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | STAR-ASTERISK-D | - |
dc.subject | MAJOR DEPRESSION | - |
dc.subject | OUTPATIENTS | - |
dc.subject | SERTRALINE | - |
dc.subject | ANXIETY | - |
dc.subject | COMORBIDITY | - |
dc.subject | VENLAFAXINE | - |
dc.subject | CITALOPRAM | - |
dc.subject | RECOVERY | - |
dc.subject | SYMPTOMS | - |
dc.title | Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Min-Soo | - |
dc.identifier.doi | 10.1002/hup.1168 | - |
dc.identifier.scopusid | 2-s2.0-79953238716 | - |
dc.identifier.wosid | 000288947300007 | - |
dc.identifier.bibliographicCitation | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, v.26, no.1, pp.41 - 50 | - |
dc.relation.isPartOf | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | - |
dc.citation.title | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | - |
dc.citation.volume | 26 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 41 | - |
dc.citation.endPage | 50 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalResearchArea | Psychology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychology | - |
dc.subject.keywordPlus | STAR-ASTERISK-D | - |
dc.subject.keywordPlus | MAJOR DEPRESSION | - |
dc.subject.keywordPlus | OUTPATIENTS | - |
dc.subject.keywordPlus | SERTRALINE | - |
dc.subject.keywordPlus | ANXIETY | - |
dc.subject.keywordPlus | COMORBIDITY | - |
dc.subject.keywordPlus | VENLAFAXINE | - |
dc.subject.keywordPlus | CITALOPRAM | - |
dc.subject.keywordPlus | RECOVERY | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordAuthor | depression | - |
dc.subject.keywordAuthor | remission | - |
dc.subject.keywordAuthor | anxiety | - |
dc.subject.keywordAuthor | parasuicide | - |
dc.subject.keywordAuthor | Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.